tiprankstipranks

Celldex price target lowered to $38 from $44 at UBS

UBS lowered the firm’s price target on Celldex (CLDX) to $38 from $44 and keeps a Buy rating on the shares.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1